Back to Search
Start Over
Hepatotoxic pyrrolizidine alkaloids induce DNA damage response in rat liver in a 28-day feeding study
- Source :
- Archives of Toxicology, Archives of toxicology, 94:1739-1751
- Publication Year :
- 2020
-
Abstract
- Pyrrolizidine alkaloids (PA) are secondary plant metabolites that occur as food and feed contaminants. Acute and subacute PA poisoning can lead to severe liver damage in humans and animals, comprising liver pain, hepatomegaly and the development of ascites due to occlusion of the hepatic sinusoids (veno-occlusive disease). Chronic exposure to low levels of PA can induce liver cirrhosis and liver cancer. However, it is not well understood which transcriptional changes are induced by PA and whether all hepatotoxic PA, regardless of their structure, induce similar responses. Therefore, a 28-day subacute rat feeding study was performed with six structurally different PA heliotrine, echimidine, lasiocarpine, senecionine, senkirkine, and platyphylline, administered at not acutely toxic doses from 0.1 to 3.3 mg/kg body weight. This dose range is relevant for humans, since consumption of contaminated tea may result in doses of ~ 8 µg/kg in adults and cases of PA ingestion by contaminated food was reported for infants with doses up to 3 mg/kg body weight. ALT and AST were not increased in all treatment groups. Whole-genome microarray analyses revealed pronounced effects on gene expression in the high-dose treatment groups resulting in a set of 36 commonly regulated genes. However, platyphylline, the only 1,2-saturated and, therefore, presumably non-hepatotoxic PA, did not induce significant expression changes. Biological functions identified to be affected by high-dose treatments (3.3 mg/kg body weight) comprise cell-cycle regulation associated with DNA damage response. These functions were found to be affected by all analyzed 1,2-unsaturated PA. In conclusion, 1,2-unsaturated hepatotoxic PA induced cell cycle regulation processes associated with DNA damage response. Similar effects were observed for all hepatotoxic PA. Effects were observed in a dose range inducing no histopathological alterations and no increase in liver enzymes. Therefore, transcriptomics studies identified changes in expression of genes known to be involved in response to genotoxic compounds at PA doses relevant to humans under worst case exposure scenarios. Electronic supplementary material The online version of this article (10.1007/s00204-020-02779-2) contains supplementary material, which is available to authorized users.
- Subjects :
- 0301 basic medicine
Cirrhosis
Drug-Related Side Effects and Adverse Reactions
DNA damage
Health, Toxicology and Mutagenesis
Gene Expression
Pharmacology
Toxicology
Letter to the Editor, News and Views
Organ Toxicity and Mechanisms
03 medical and health sciences
chemistry.chemical_compound
Structure-Activity Relationship
0302 clinical medicine
Ascites
Gene expression
medicine
Ingestion
Animals
Humans
Transcriptomics
Pyrrolizidine Alkaloids
business.industry
Pyrrolizidine alkaloids
Hepatotoxicity
Liver Neoplasms
General Medicine
Plants
medicine.disease
Rats
030104 developmental biology
chemistry
Liver
030220 oncology & carcinogenesis
Pyrrolizidine
Chemical and Drug Induced Liver Injury
medicine.symptom
Liver cancer
business
Senecionine
DNA Damage
Subjects
Details
- ISSN :
- 14320738
- Volume :
- 94
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Archives of toxicology
- Accession number :
- edsair.doi.dedup.....23ea59e0fadc047a09ebabf45e7c6eb6